| Functional Effects of KCNE3 Mutation and Its Role in the Development of Brugada Syndrome (vol 1, pg 209, 2008) E Delpon, JM Cordeiro, L Nunez, PEB Thomsen, A Guerchicoff, ... CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY 1 (5), E2-E2, 2008 | 414* | 2008 |
| Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome E Delpón, JM Cordeiro, L Núñez, PEB Thomsen, A Guerchicoff, ... Circulation: Arrhythmia and Electrophysiology 1 (3), 209-218, 2008 | 414 | 2008 |
| Nitric oxide blocks hKv1. 5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism L Núñez, M Vaquero, R Gómez, R Caballero, P Mateos-Cáceres, ... Cardiovascular research 72 (1), 80-89, 2006 | 112 | 2006 |
| Insights into genotype–phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3 MJ Oliva-Sandoval, F Ruiz-Espejo, L Monserrat, M Hermida-Prieto, ... Heart 96 (24), 1980-1984, 2010 | 89 | 2010 |
| Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy J Tamargo, R Caballero, R Gómez, L Núñez, M Vaquero, E Delpón Pharmacology & therapeutics 114 (1), 107-126, 2007 | 84 | 2007 |
| Effects of atorvastatin and simvastatin on atrial plateau currents M Vaquero, R Caballero, R Gomez, L Nunez, J Tamargo, E Delpón Journal of molecular and cellular cardiology 42 (5), 931-945, 2007 | 79 | 2007 |
| Nitric oxide inhibits Kv4. 3 and human cardiac transient outward potassium current (Ito1) R Gómez, L Núñez, M Vaquero, I Amorós, A Barana, T de Prada, ... Cardiovascular research 80 (3), 375-384, 2008 | 68 | 2008 |
| NO inhibits Kv4. 3 and human cardiac transient outward potassium current (Ito1) R Gómez, L Núñez, M Vaquero, I Amorós, A Barana, T de Prada, ... | 68* | 2008 |
| Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current R Caballero, R Gómez, I Moreno, L Nuñez, T González, C Arias, M Guizy, ... Cardiovascular research 62 (1), 86-95, 2004 | 66 | 2004 |
| Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization E Delpón, R Caballero, R Gómez, L Núñez, J Tamargo Trends in pharmacological sciences 26 (3), 155-161, 2005 | 61 | 2005 |
| p. D1690N Nav1. 5 rescues p. G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient L Núñez, A Barana, I Amorós, MG de la Fuente, P Dolz-Gaitón, R Gómez, ... Heart Rhythm 10 (2), 264-272, 2013 | 51 | 2013 |
| Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy MI Rodríguez-García, L Monserrat, M Ortiz, X Fernández, L Cazón, ... BMC medical genetics 11 (1), 67, 2010 | 51 | 2010 |
| Association of 14-3-3 proteins to β1-adrenergic receptors modulates Kv11. 1 K+ channel activity in recombinant systems AS Tutor, E Delpón, R Caballero, R Gómez, L Núñez, M Vaquero, ... Molecular biology of the cell 17 (11), 4666-4674, 2006 | 45 | 2006 |
| Spironolactone and its main metabolite canrenoic acid block hKv1. 5, Kv4. 3 and Kv7. 1+ minK channels R Gómez, L Núñez, R Caballero, M Vaquero, J Tamargo, E Delpón British journal of pharmacology 146 (1), 146-161, 2005 | 40 | 2005 |
| Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy. L Núñez, JR Gimeno-Blanes, MI Rodríguez-García, L Monserrat, E Zorio, ... Circulation journal: official journal of the Japanese Circulation Society, 2013 | 33 | 2013 |
| Diltiazem inhibits hKv1. 5 and Kv4. 3 currents at therapeutic concentrations R Caballero, R Gómez, L Núñez, I Moreno, J Tamargo, E Delpón Cardiovascular research 64 (3), 457-466, 2004 | 32 | 2004 |
| Características farmacológicas de los ARA-II.¿ Son todos iguales? J Tamargo, R Caballero, R Gómez, L Núñez, M Vaquero, E Delpón Revista Española de Cardiología Suplementos 6 (3), 10C-24C, 2006 | 31 | 2006 |
| Pharmacology of omega 3 polyinsaturated fatty acids R Caballero, R Gómez, L Núñez, M Vaquero, J Tamargo, E Delpón Rev Esp Cardiol 6 (Suppl D), 3-19, 2006 | 27* | 2006 |
| Effects of MiRP1 and DPP6 β‐subunits on the blockade induced by flecainide of KV4. 3/KChIP2 channels S Radicke, M Vaquero, R Caballero, R Gomez, L Nunez, J Tamargo, ... British journal of pharmacology 154 (4), 774-786, 2008 | 26 | 2008 |
| Genetically engineered mice as a model for studying cardiac arrhythmias J Tamargo, R Caballero, L Núñez, R Gómez, M Vaquero, E Delpón Front Biosci 12, 22-38, 2007 | 25 | 2007 |
